Brief: Candel Therapeutics Reports First Quarter 2022 Financial Results

Candel Therapeutics

12/05/2022 13:29

May 12 (Reuters) - Candel Therapeutics Inc  CADL.O :
    * CANDEL THERAPEUTICS REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS
AND RECENT CORPORATE HIGHLIGHTS
    * CASH AND CASH EQUIVALENTS AS OF MARCH 31, 2022 WERE $94.3
MILLION COMPARED TO $82.6 MILLION AS OF DECEMBER 31, 2021
    * CASH AND CASH EQUIVALENTS AS OF MARCH 31, 2022 WERE $94.3
MILLION
    * EXPECTS THAT ITS EXISTING CASH AND CASH EQUIVALENTS WILL
BE
SUFFICIENT TO FUND ITS OPERATIONS INTO Q4 OF 2023
    * QTRLY LOSS PER SHARE $0.03

Source text for Eikon:  ID:nGNX47WtZr 
Further company coverage:  CADL.O 

 ((Reuters.Briefs@thomsonreuters.com;))